Suppr超能文献

新型 SV2A 放射性示踪剂 [18F]UCB-H 的临床前放射剂量学研究。

Preclinical radiation dosimetry for the novel SV2A radiotracer [18F]UCB-H.

机构信息

Cyclotron Research Centre, University of Liège, Allée du 6 Août, Building B30, Sart Tilman, Liège 4000, Belgium.

出版信息

EJNMMI Res. 2013 May 7;3(1):35. doi: 10.1186/2191-219X-3-35.

Abstract

BACKGROUND

[18F]UCB-H was developed as a novel radiotracer with a high affinity for synaptic vesicle protein 2A, the binding site for the antiepileptic levetiracetam. The objectives of this study were to evaluate the radiation dosimetry of [18F]UCB-H in a preclinical trial and to determine the maximum injectable dose according to guidelines for human biomedical research. The radiation dosimetry was derived by organ harvesting and dynamic micro positron emission tomography (PET) imaging in mice, and the results of both methods were compared.

METHODS

Twenty-four male C57BL-6 mice were injected with 6.96 ± 0.81 MBq of [18F]UCB-H, and the biodistribution was determined by organ harvesting at 2, 5, 10, 30, 60, and 120 min (n = 4 for each time point). Dynamic microPET imaging was performed on five male C57BL-6 mice after the injection of 9.19 ± 3.40 MBq of [18F]UCB-H. A theoretical dynamic bladder model was applied to simulate urinary excretion. Human radiation dose estimates were derived from animal data using the International Commission on Radiological Protection 103 tissue weighting factors.

RESULTS

Based on organ harvesting, the urinary bladder wall, liver and brain received the highest radiation dose with a resulting effective dose of 1.88E-02 mSv/MBq. Based on dynamic imaging an effective dose of 1.86E-02 mSv/MBq was calculated, with the urinary bladder wall and liver (brain was not in the imaging field of view) receiving the highest radiation.

CONCLUSIONS

This first preclinical dosimetry study of [18F]UCB-H showed that the tracer meets the standard criteria for radiation exposure in clinical studies. The dose-limiting organ based on US Food and Drug Administration (FDA) and European guidelines was the urinary bladder wall for FDA and the effective dose for Europe with a maximum injectable single dose of approximately 325 MBq was calculated. Although microPET imaging showed significant deviations from organ harvesting, the Pearson's correlation coefficient between radiation dosimetry derived by either method was 0.9666.

摘要

背景

[18F]UCB-H 是一种新型放射性示踪剂,对突触囊泡蛋白 2A 具有高亲和力,后者是抗癫痫药左乙拉西坦的结合位点。本研究的目的是评估 [18F]UCB-H 的临床前试验中的辐射剂量,并根据人类生物医学研究的指南确定最大可注射剂量。通过器官收获和动态微正电子发射断层扫描 (PET) 成像在小鼠中得出辐射剂量,并比较两种方法的结果。

方法

24 只雄性 C57BL-6 小鼠注射 6.96±0.81MBq[18F]UCB-H,通过器官收获在 2、5、10、30、60 和 120 分钟时(每个时间点 4 只)确定生物分布。在 5 只雄性 C57BL-6 小鼠注射 9.19±3.40MBq[18F]UCB-H 后进行动态微 PET 成像。应用理论动态膀胱模型模拟尿排泄。从动物数据中得出人体辐射剂量估算值,使用国际辐射防护委员会 103 种组织权重因子。

结果

根据器官收获,膀胱壁、肝脏和大脑接收到最高的辐射剂量,导致有效剂量为 1.88E-02mSv/MBq。根据动态成像,计算出有效剂量为 1.86E-02mSv/MBq,膀胱壁和肝脏(大脑不在成像视野内)接收到最高的辐射。

结论

这是 [18F]UCB-H 的首次临床前剂量学研究,表明示踪剂符合临床研究中辐射暴露的标准标准。基于美国食品和药物管理局 (FDA) 和欧洲指南的剂量限制器官是膀胱壁,基于 FDA 的有效剂量和欧洲的最大可注射单剂量约为 325MBq。尽管微 PET 成像显示与器官收获有显著差异,但两种方法得出的辐射剂量学之间的 Pearson 相关系数为 0.9666。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9b2/3655042/d6796ef5fc38/2191-219X-3-35-1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验